We are live on ! Find out more
QTTB icon

Q32 Bio

54 hedge funds and large institutions have $144M invested in Q32 Bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 5

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

38% more funds holding

Funds holding: 3954 (+15)

15% more capital invested

Capital invested by funds: $126M → $144M (+$18.3M)

162.49% less ownership

Funds ownership: 230.04%67.55% (-162%)

Holders
54
Holders Change
+15
Holders Change %
+38.46%
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
20
Increased
16
Reduced
6
Closed
5
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$192K

QTTB Hedge Fund Activity: Q2 2024 in Review

54 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2024, worth a combined $144M — up 15% from $126M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new QTTB positions and 5 closed out — a net gain of 15 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $7.12M. The largest seller was Vivo Capital, cutting an estimated $8.36M.

  • 54 institutional investors held Q32 Bio (QTTB) as of Q2 2024, up from 39 in Q1 2024.
  • Funds reported $144M of Q32 Bio stock for Q2 2024, up 15% quarter-over-quarter.
  • 20 funds opened new Q32 Bio positions in Q2 2024 and 5 closed out, a net change of +15 holders.
  • The largest Q32 Bio buyer in Q2 2024 was BlackRock, an estimated $7.12M added.
  • The largest Q32 Bio seller in Q2 2024 was Vivo Capital, an estimated $8.36M sold.

Based on aggregated 13F filings for Q2 2024.